Abstract
Background:Up to 30% of patients with operable breast cancer and negative regional lymph nodes experience disease recurrence within 10 years. Serial sectioning and immunohistochemical staining of these nodes have revealed 9% to 30% occult metastases.
Methods:Sentinel nodes from 200 patients with T1 and T2 invasive breast carcinoma were step-sectioned at 2- to 3-mm intervals, fixed in 10% formalin, and embedded in paraffin. Sections were taken from the face of the blocks and stained with hematoxylin and eosin (H&E). The blocks were then cut completely, and sections at .25-mm intervals were stained with cytokeratin and examined.
Results:Tumor metastases were found in 34 patients when the sentinel nodes were examined at 2- to 3-mm intervals and in an additional 51 patients when the nodes were sectioned in their entirety at .25-mm intervals and stained with cytokeratin, bringing the total number of patients with metastases to 85. Of the 51 patients whose metastases were detected by 2- to 3-mm sectioning and cytokeratin staining, 27 had isolated tumor cells and 24 had clusters of innumerable malignant cells, all of which were visualized and confirmed by H&E staining of the adjacent sections.
Conclusions:Histologic examination of sentinel nodes of patients with invasive breast cancer sectioned at 2- to 3-mm intervals and stained with H&E significantly underestimates nodal metastases. Sectioning of the entire sentinel nodes at .25-mm intervals and staining with cytokeratin detects metastases as either isolated cells or as clusters.
Similar content being viewed by others
REFERENCES
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818–1822.
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–2350.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941–946.
Snider H, Dowlatshahi K, Fan M, et al. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998;176:305–310.
Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–373.
Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;42:2025–2031.
Friedman S, Bertin F, Mouriesse H, et al. Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol 1988;27:483–487.
InstitutionalAuthorNameInternational (Ludwig) Breast Cancer Study Group (1990) ArticleTitlePrognostic importance of occult axillary lymph node micrometastases from breast cancer Lancet 335 1565–1568
Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993;80:459–463.
Nasser IA, Lee A, Bosari S, et al. Occult axillary lymph node metastases in “node-negative” breast carcinoma. Hum Pathol 1993;24:950–957.
McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88–95.
Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;354:896–900.
Schreiber RH, Pendas S, Ku NN, et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999;6:95–101.
Weaver DL, Krag DN, Ashikaga T, et al. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000;88:1099–1107.
Jannink I, Fan M, Nagy S, et al. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998;5:310–315.
Dowlatshahi K, Fan M, Bloom KJ, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999;86:990–996.
Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645–651.
Gusterson BA, Ott R. Occult axillary lymph node micrometastases in breast cancer. Lancet 1990;336:434–435.
Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. Philadelphia: Lippincott-Raven Publishers, 1997.
Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188–1197.
Hsueh EC, Hansen N, Giuliano AE. Intraoperative lymphatic mapping and sentinel node dissection in breast cancer. Cancer 2000;50:279–291.
Lucci A, Kelemen PR, Miller C, et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192:453–458.
Bauer KD, Torre-Bueno J, Diel IJ, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000;6:3552–3559.
Youngson BJ, Cranor M, Rosen PP. Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 1994;18:896–903.
Youngson BJ, Lieberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 1995;103:598–602.
Rosser RJ. A point of view: trauma is the cause of occult micrometastatic breast cancer in sentinel axillary lymph nodes. Breast J 2000;6:209–212.
Carter BA, Jensen RA, Simpson JF, et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000;113:259–265.
Klauber-DeMore N, Tan LK, Lieberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in-situ and ductal carcinoma in-situ with microinvasion?. Ann Surg Oncol 2000;7:636–642.
Pendas S, Dauway E, Giulian R, et al. Sentinel node biopsy in ductal carcinoma in-situ patients. Ann Surg Oncol 2000;7:15–20.
Tabar L, Duff SW, Vitkas B, et al. The natural history of breast carcinoma: what have we learned from screening?. Cancer 1999;86:449–462.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dowlatshahi, K., Fan, M., Anderson, J.M. et al. Occult Metastases in Sentinel Nodes of 200 Patients With Operable Breast Cancer. Ann Surg Oncol 8, 675–681 (2001). https://doi.org/10.1007/s10434-001-0675-3
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-001-0675-3